Validation of an Index for Functionally Important Respiratory Symptoms among Adults in the Nationally Representative Population Assessment of Tobacco and Health Study, 2014–2016

The purpose of this study is to validate the seven-item wheezing module from the International Study of Asthma and Allergies in Children (ISAAC) in the nationally representative Population Assessment of Tobacco and Health Study. Adult participants with complete Wave 2–3 data were selected, including those with asthma but excluding those with COPD and other respiratory diseases (n = 16,295). We created a nine-point respiratory symptom index from the ISAAC questions, assessed the reliability of the index, and examined associations with self-reported asthma diagnosis. Threshold values were assessed for association with functional outcomes. The weighted prevalence for one or more respiratory symptom was 18.0% (SE = 0.5) for adults without asthma, 70.1% (SE = 1.3) for those with lifetime asthma, 75.7% (SE = 3.7) for adults with past-year asthma not on medications, and 92.6% (SE = 1.6) for those on medications. Cronbach’s alpha for the respiratory symptom index was 0.86. Index scores of ≥2 or ≥3 yielded functionally important respiratory symptom prevalence of 7–10%, adequate sensitivity and specificity for identifying asthma, and consistent independent associations with all functional outcomes and tobacco use variables. Respiratory symptom index scores of ≥2 or ≥3 are indicative of functionally important respiratory symptoms and could be used to assess the relationship between tobacco use and respiratory health.

[1]  A. Hyland,et al.  Longitudinal Uses of the Population Assessment of Tobacco and Health Study. , 2021, Tobacco regulatory science.

[2]  D. Strachan,et al.  Global Asthma Network Phase I Surveillance: Geographical Coverage and Response Rates , 2020, Journal of clinical medicine.

[3]  Francesco Lancia,et al.  Replication Data for: Youth Enfranchisement, Political Responsiveness, and Education Expenditure: Evidence from the U.S. In Nashville, TN: American Economic Association [publisher]. Inter-university Consortium for Political and Social Research [distributor] , 2020 .

[4]  R. Tourangeau,et al.  Population Assessment of Tobacco and Health (PATH) reliability and validity study: selected reliability and validity estimates , 2018, Tobacco Control.

[5]  D. Strachan,et al.  The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors , 2017, European Respiratory Journal.

[6]  K. Cummings,et al.  Design and methods of the Population Assessment of Tobacco and Health (PATH) Study , 2016, Tobacco Control.

[7]  Meilan K. Han,et al.  Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality. , 2015, Annals of the American Thoracic Society.

[8]  J. Fries,et al.  Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients , 2015, Quality of Life Research.

[9]  L. Petecchia,et al.  Smoke exposure, wheezing, and asthma development: A systematic review and meta‐analysis in unselected birth cohorts , 2015, Pediatric pulmonology.

[10]  D. Mannino,et al.  Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. , 2013, Chest.

[11]  Daniel J Buysse,et al.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. , 2010, Journal of clinical epidemiology.

[12]  A. Zellner,et al.  INTRODUCTION TO MEASUREMENT WITH THEORY , 2009, Macroeconomic Dynamics.

[13]  E. Symanski,et al.  Prevalence of Asthma among Adult Females and Males in the United States: Results from the National Health and Nutrition Examination Survey (NHANES), 2001–2004 , 2009 .

[14]  E. Symanski,et al.  Prevalence of asthma among adult females and males in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2001-2004. , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[15]  N. Pearce,et al.  Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) , 2007, Thorax.

[16]  Philip,et al.  Pseudoreplication Further Evaluation and Application of the Balanced Half-Sample Technique , 2001 .

[17]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[18]  N. Santanello,et al.  Validation of an asthma symptom diary for interventional studies , 1999, Archives of disease in childhood.

[19]  R. Zeiger,et al.  Construction and validation of four childhood asthma self-management scales: parent barriers, child and parent self-efficacy, and parent belief in treatment efficacy. , 1999, Journal of Asthma.

[20]  J. Baraniuk,et al.  Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. , 1997, The Journal of allergy and clinical immunology.

[21]  D. Strachan,et al.  International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. , 1995, The European respiratory journal.

[22]  L. Rivest.  Statistical properties of Winsorized means for skewed distributions , 1994 .

[23]  D. Strachan,et al.  Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. , 1993, The European respiratory journal.

[24]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.